Elaprase and disease progression Patient Reports February 13, 2012
Elaprase Side Effects Report #6093002-3
Elaprase side effect was reported by a Health Professional from UNITED STATES on Feb 11, 2009. Male patient, 14 years of age, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase. After drug was administered, patient experienced the following side effects: disease progression, grand mal convulsion, mucopolysaccharidosis ii. Elaprase dosage: unknown. Patient was hospitalized. Patient recovered.
Elaprase Side Effects Report #5526067-5
Elaprase side effect was reported by a Physician from FRANCE on Nov 08, 2007. Male patient, child 11 years of age, weighting 57.32 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase. After drug was administered, patient experienced the following side effects: disease progression, eczema
, grand mal convulsion, mucopolysaccharidosis ii, urticaria. Elaprase dosage: 18 MG, 1X/WEEK, IV DRIP. Patient was hospitalized. Patient recovered.Elaprase Side Effects Report #6076979-1
Elaprase side effect was reported by a Health Professional from UNITED STATES on Jan 27, 2009. Male patient was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase. After drug was administered, patient experienced the following side effects: convulsion, cough, disease progression, hydrocephalus
, nasal congestion, pyrexia. Elaprase dosage: 12 MG, 1X/WEEK, IV DRIP. Patient was hospitalized. Patient recovered.Elaprase Side Effects Report #6084993-5
Elaprase side effect was reported by a Health Professional from UNITED STATES on Feb 05, 2009. Male patient was diagnosed with mucopolysaccharidosis ii and was treated with Elaprase. After drug was administered, patient experienced the following side effects: condition aggravated, convulsion, cough, disease progression, hydrocephalus
, nasal congestion, pyrexia. Elaprase dosage: 12 MG, 1X/WEEK, IV DRIP. Patient was hospitalized. Patient recovered.
Elaprase and disease progression 